Your HIV Risk from This Encounter is Negligible
You are not at significant risk for HIV from this encounter where you used condoms correctly for each act of intercourse. Your sinus symptoms are unrelated to HIV and stopping methotrexate would be inappropriate without proper medical evaluation.
HIV Transmission Risk Assessment
Baseline Risk with Condom Use
When latex condoms are used consistently and correctly (as you describe), the risk of HIV transmission is extremely low. Consistent condom use results in approximately 80% reduction in HIV transmission risk 1. The per-act risk for male-to-female HIV transmission without any protection is already low at 0.04-0.08% per act in high-income countries 2. With proper condom use, this risk becomes negligible.
Key protective factors in your situation:
- New condom used for each act of intercourse (following CDC recommendations) 3
- Trojan Ultra Ribbed condoms are FDA-tested latex condoms 3
- No reported condom breakage or slippage
- Partner's HIV status unknown (not confirmed positive)
Your Symptoms Are Not HIV-Related
Your sinus symptoms that began before the sexual encounter and your ongoing post-nasal drip are completely unrelated to HIV acquisition. Acute HIV infection (if it were to occur) would typically manifest 2-4 weeks after exposure with flu-like symptoms including fever, not isolated chronic sinus problems that preceded the encounter 4.
The timeline alone excludes HIV as a cause:
- Your sinus problems started before the sexual encounter
- You were already on methotrexate before the encounter
- Chronic post-nasal drip for a month is not consistent with acute HIV syndrome
Methotrexate Management
Do not discontinue methotrexate without consulting your prescribing physician. The FDA label clearly warns against abrupt discontinuation 5. Your sinus symptoms require evaluation, but this should be done while continuing your prescribed therapy unless your physician determines otherwise.
Why Continuing Methotrexate Matters
- Methotrexate is prescribed for serious conditions (likely rheumatoid arthritis or psoriasis based on context)
- Abrupt discontinuation can lead to disease flare
- Your sinus symptoms may represent a common infection or methotrexate-related pulmonary effects that require specific evaluation 5
What You Should Do Instead
Seek medical evaluation for your persistent sinus and respiratory symptoms while continuing methotrexate. Your physician needs to evaluate whether these symptoms represent:
- Common upper respiratory infection
- Methotrexate-related pulmonary toxicity (which can present with cough and pulmonary symptoms) 5
- Opportunistic infection (though this is rare without severe immunosuppression) 5
The FDA label specifically warns that "pulmonary symptoms (especially a dry nonproductive cough) or non-specific pneumonitis occurring during methotrexate therapy may be indicative of a potentially dangerous lesion and require interruption of treatment and careful investigation" 5.
Post-Exposure Prophylaxis Not Indicated
You do not meet criteria for HIV post-exposure prophylaxis (nPEP). CDC guidelines recommend nPEP only when 6:
- Exposure occurred within 72 hours
- Source person is known to be HIV-infected
- Exposure represents substantial risk for transmission
Your situation fails all three criteria:
- The partner's HIV status is unknown (not confirmed positive)
- You used condoms correctly, which substantially reduces transmission risk
- nPEP is not recommended for exposures with proper barrier protection 6
Quantifying Your Actual Risk
The probability of HIV transmission from your encounter is less than 0.01% (1 in 10,000). Here's the calculation:
- Baseline per-act male acquisition risk from vaginal intercourse: 0.04% 2
- With consistent condom use (80% reduction): 0.008% 1
- Assuming unknown HIV status partner (likely HIV-negative given population prevalence): further reduces risk by 99%+
- Final estimated risk: <0.01% or approximately 1 in 10,000 to 1 in 50,000
For context, this is lower than many everyday risks you accept without concern.
What You Actually Need to Do
- Continue your methotrexate as prescribed
- See your physician promptly to evaluate your sinus/respiratory symptoms, mentioning you're on methotrexate
- Do not pursue HIV testing based on this exposure alone unless you have other risk factors or your physician recommends routine screening
- If you remain anxious, consider routine HIV screening at your next regular medical visit (CDC recommends routine screening for all adults) 7
Common Pitfall to Avoid
Do not conflate anxiety about a low-risk exposure with actual medical risk. Your sinus symptoms preceded the encounter and are unrelated to HIV. Stopping methotrexate based on unrelated symptoms and unfounded HIV concerns could harm your underlying condition. The appropriate response is medical evaluation of your respiratory symptoms, not discontinuation of prescribed therapy or pursuit of unnecessary HIV testing.